Skip to content
Menu

Innate Pharma S.A. IPHA

Full chart Compare
Set alert

Price alert · IPHA

All alert types
0.86 USD -0.08 (-8.14%)

Regular-session close

0.86 0.00 0.00%

After hours · Nov 20, 4:00 PM ET

0.829 Day range 0.9084
0.829 52-week range 2.71
YTD
-50.66%
1 year
-52.56%

Ownership

  • Institutions 0.50%
  • Insiders 0.00%
  • Public and other holders 99.5%
Held by insiders 0.00%
Held by institutions 0.50%
Float held by institutions 0.50%
Institutions 11

Top institutional holders

Top institutional holders
Holder% heldSharesValueReported
Optiver Holding B.v.0.10%86,788182.25KSep 29, 2024
Exchange Traded Concepts LLC0.09%77,350162.43KSep 29, 2024
Morgan Stanley0.05%43,52491.40KSep 29, 2024
Citadel Advisors Llc0.03%21,26744.66KSep 29, 2024
UBS Group AG0.01%8,40817.66KSep 29, 2024
Rhumbline Advisers0.00%205430Sep 29, 2024

Top mutual fund holders

Top mutual fund holders
Holder% heldSharesValueReported
ETF Series Solutions-Range Cancer Therapeutics ETF0.09%73,688154.74KAug 30, 2024
Trust for Professional Managers-ActivePassive International Equity ETF0.08%64,826136.13KAug 30, 2024

Included in Plus and up

Sign in to see Institutional ownership

How much funds own from their 13F filings, quarter by quarter, and the largest holders.

Free with an account

Sign in to see Insider activity

Two years of insider buying and selling by month, marked on the price.

Included in Plus and up

Sign in to see Congress trading

Every stock trade disclosed by members of the US Senate and House.

Free with an account

Sign in to see CEO compensation

What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.

Free with an account

Sign in to see Board of directors

Who sits on the board, who chairs it, and how long each director has served.

No insider holdings on record